<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-129347" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neonatal Therapeutic Hypothermia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sakr</surname>
            <given-names>Mohamed</given-names>
          </name>
          <aff>Brookdale Hospital Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Manan</given-names>
          </name>
          <aff>Rutgers University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Balasundaram</surname>
            <given-names>Palanikumar</given-names>
          </name>
          <aff>University of Illinois College Medicine of Rockford, &#x00026; Javon Bea Hospital, Mercy Health System, IL</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohamed Sakr declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Manan Shah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Palanikumar Balasundaram declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-129347.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hypoxic-ischemic encephalopathy among neonates is a significant cause of infant mortality and neurodevelopmental deficits. It is caused by a lack of oxygen to the brain at birth. It is evident from many systematic reviews that therapeutic hypothermia is beneficial in neonates with moderate to severe hypoxic-ischemic encephalopathy. Many unanswered questions regarding indications, target timing, and appropriate populations exist. There are also critical pathophysiological&#x000a0;concepts that need to be understood. This activity reviews therapeutic hypothermia's indications, preparation, technique, and complications. Also, it highlights the role of the interprofessional team in evaluating and treating neonates under therapeutic hypothermia.</p>
        <p>Clinicians&#x000a0;can expect to gain&#x000a0;the necessary knowledge to make informed decisions regarding the use of therapeutic hypothermia in neonatal care. Furthermore, this&#x000a0;activity will address crucial unanswered questions surrounding therapeutic hypothermia, including indications, target timing, and appropriate populations. Controversial aspects, such as the efficacy of therapeutic hypothermia in low and middle-income countries and its application in premature babies under 35 weeks of gestation, will be explored. By participating in this activity, clinicians gain insights into the ongoing research on these topics and the evolving standards of care.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between neonates with moderate to severe hypoxic-ischemic encephalopathy who are appropriate candidates for therapeutic hypothermia and those in whom it may be controversial or less beneficial.</p></list-item><list-item><p>Assess and recognize short-term adverse effects of therapeutic hypothermia, ensuring prompt intervention and continuous evaluation of the neonatal response and overall well-being.</p></list-item><list-item><p>Implement therapeutic hypothermia in accordance with established guidelines, ensuring timely initiation, appropriate temperature management, and close monitoring to optimize outcomes for neonates with hypoxic-ischemic encephalopathy.</p></list-item><list-item><p>Collaborate with&#x000a0;an interprofessional healthcare team, engaging in multidisciplinary discussions to optimize the evaluation, treatment, and follow-up care for neonates undergoing therapeutic hypothermia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=129347&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=129347">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-129347.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hypoxic-ischemic encephalopathy (HIE) results from oxygen deprivation during the perinatal period and is a significant cause of infant mortality and neurodevelopmental deficits in neonates.<xref ref-type="bibr" rid="article-129347.r1">[1]</xref> It is a significant health&#x000a0;problem throughout the world. According to recent data, neonatal HIE incidence varies, with the most accepted rate of 1.5 per 1000 live births in developed countries; however, other studies show a significantly higher estimate.<xref ref-type="bibr" rid="article-129347.r2">[2]</xref><xref ref-type="bibr" rid="article-129347.r3">[3]</xref>&#x000a0;The incidence in developing countries tends to be much higher, with estimates as high as 30 per 1000 births.<xref ref-type="bibr" rid="article-129347.r4">[4]</xref><xref ref-type="bibr" rid="article-129347.r5">[5]</xref><xref ref-type="bibr" rid="article-129347.r2">[2]</xref><xref ref-type="bibr" rid="article-129347.r6">[6]</xref></p>
        <p>The long-term morbidity and mortality for infants with&#x000a0;HIE varies, with mortality rates ranging from 10% to 60% and neurodevelopmental disabilities in many survivors.<xref ref-type="bibr" rid="article-129347.r7">[7]</xref><xref ref-type="bibr" rid="article-129347.r6">[6]</xref><xref ref-type="bibr" rid="article-129347.r8">[8]</xref>&#x000a0;A systematic review concluded that therapeutic hypothermia is beneficial in neonates with HIE.<xref ref-type="bibr" rid="article-129347.r9">[9]</xref>&#x000a0;</p>
        <p>While it is accepted that parents of all term neonates with moderate or severe&#x000a0;HIE should be offered therapeutic hypothermia, it is essential to note that there are several populations where&#x000a0;therapeutic hypothermia is controversial or has shown little to no benefit.</p>
        <p>
<bold>Low- and Middle-Income Countries</bold>
</p>
        <p>A recent meta-analysis of&#x000a0;10 studies showed that therapeutic hypothermia in these settings showed little to no benefit in reducing death or severe disability. In addition,&#x000a0;therapeutic hypothermia was associated with increased bleeding and thrombocytopenia.<xref ref-type="bibr" rid="article-129347.r10">[10]</xref>&#x000a0;However, this is controversial, and many experts advocate for continuing therapeutic hypothermia in these settings.<xref ref-type="bibr" rid="article-129347.r11">[11]</xref><xref ref-type="bibr" rid="article-129347.r12">[12]</xref></p>
        <p>
<bold>Premature Babies Under 35 Weeks of Gestation</bold>
</p>
        <p>Retrospective analysis of preterm infants undergoing&#x000a0;therapeutic hypothermia has resulted in concerning findings and the rate of adverse events.<xref ref-type="bibr" rid="article-129347.r13">[13]</xref><xref ref-type="bibr" rid="article-129347.r14">[14]</xref>&#x000a0;A large randomized trial is underway&#x000a0;to answer this question in this vulnerable population, and it is not currently the accepted standard of care to initiate&#x000a0;therapeutic hypothermia in this population.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Therapeutic hypothermia for mild hypoxic-ischemic encephalopathy</bold>
<list list-type="bullet"><list-item><p>Published data show babies with mild HIE are at significant risk of having lower cognitive scores than those without mild HIE.<xref ref-type="bibr" rid="article-129347.r15">[15]</xref>&#x000a0;However, it is unclear if&#x000a0;therapeutic hypothermia benefits this population, and additional studies are needed to determine the long-term risks and benefits of therapeutic hypothermia in this group of babies.<xref ref-type="bibr" rid="article-129347.r16">[16]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Late initiation of therapeutic hypothermia (6-24 hours after birth)</bold>
<list list-type="bullet"><list-item><p>It is often impossible to begin therapeutic hypothermia within the accepted 6-hour time window studied in large randomized controlled trials. A recent randomized clinical trial showed that using Bayesian analysis, there was a 64% probability of benefit in death or disability.<xref ref-type="bibr" rid="article-129347.r17">[17]</xref> However, changing current practices based on this analysis is controversial, and most centers have not implemented late cooling as a standard of care.<xref ref-type="bibr" rid="article-129347.r18">[18]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Longer (120 hours vs 72 hours) or deeper (32 &#x000b0;C vs 33.5 &#x000b0;C)</bold>
<list list-type="bullet"><list-item><p>In a randomized trial, longer or deeper&#x000a0;therapeutic hypothermia did not show any benefit in outcomes at 18 months of age.<xref ref-type="bibr" rid="article-129347.r19">[19]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-129347.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>The mechanism of injury occurs in multiple steps, with an initial insult, followed by a latent (30 minutes-6 hours), secondary (6-12 hours to 3 days), and tertiary phase (months).<xref ref-type="bibr" rid="article-129347.r20">[20]</xref></p>
        <list list-type="order">
          <list-item>
            <p>Initially, if the hypoxic insult is severe, there is an immediate decrease or cessation of glucose delivery, which causes ATP production to fail, resulting in primary neuronal death. For a more moderate injury, the brain will preferentially maintain circulation to critical areas such as the brainstem at the expense of the cerebral cortex and cerebral hemispheres, with the thalamus and basal ganglia most acutely affected.<xref ref-type="bibr" rid="article-129347.r20">[20]</xref>&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>The latent phase begins within the first hour, assuming the oxygen supply is restored, and lasts 6 to 12 hours. In this phase, there is some recovery of the intracellular processes, as well as increased inflammation and further neuronal death due to apoptotic cascades.<xref ref-type="bibr" rid="article-129347.r20">[20]</xref> This is the phase that is usually targeted with therapeutic hypothermia.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The secondary phase begins after the latent phase and is characterized by free radical injury, mitochondrial failure, cell death, and possible clinical deterioration, often leading to seizures.<xref ref-type="bibr" rid="article-129347.r21">[21]</xref><xref ref-type="bibr" rid="article-129347.r22">[22]</xref>.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>The tertiary phase follows and lasts months, involving remodeling and late cell death.<xref ref-type="bibr" rid="article-129347.r20">[20]</xref><xref ref-type="bibr" rid="article-129347.r23">[23]</xref></p>
          </list-item>
        </list>
        <p>The latent period between primary and secondary neuronal death is approximately 6 hours, and this is the window of opportunity to initiate therapeutic hypothermia, which is thought to help by reducing the cerebral metabolic rate, as well as other mechanisms such as reduced inflammation, reduced apoptosis as well as suppression of abnormal receptor activity.<xref ref-type="bibr" rid="article-129347.r24">[24]</xref><xref ref-type="bibr" rid="article-129347.r25">[25]</xref></p>
      </sec>
      <sec id="article-129347.s4" sec-type="Indications">
        <title>Indications</title>
        <p>There are various inclusion criteria for the initiation of therapeutic hypothermia. The most commonly used inclusion criteria&#x000a0;are based on the&#x000a0;New England Journal of Medicine study, which&#x000a0;showed the benefit of therapeutic hypothermia for infants with moderate to severe encephalopathy.<xref ref-type="bibr" rid="article-129347.r1">[1]</xref></p>
        <p>To qualify for therapeutic hypothermia, the infant must meet all&#x000a0;3 of the criteria below (demographic, biochemical, and examination):</p>
        <p>
<bold>Demographic Criteria:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Gestational age 36 weeks or greater</p>
          </list-item>
          <list-item>
            <p>Birth weight &#x02265;1800 grams</p>
          </list-item>
          <list-item>
            <p>The infant is within&#x000a0;6 hours of birth</p>
          </list-item>
        </list>
        <p>
<bold>Biochemical Criteria:</bold>
</p>
        <p>1. The infant's blood gas within the first hour of life (can be from cord blood or the baby's blood) has a pH of &#x02264;7.0 or a base deficit of &#x02265;16 mmol/L. If true, the infant meets the biochemical criteria and can proceed immediately with the <bold>examination criteria</bold>.</p>
        <p>2. If, on the other hand, the infant's blood gas has a pH &#x02265;7.0 but &#x02264;7.15&#x000a0;<bold>or</bold> has a base deficit between 10 to15.9 mmol/L, or if there is no gas available within an hour, then the following additional criteria&#x000a0;are required to move onto the <bold>examination criteria:&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</bold>&#x000a0; &#x000a0;</p>
        <p>&#x000a0; &#x000a0;A) Acute perinatal event (including but not limited to trauma, rupture, prolapse, etc) <bold>and&#x000a0; &#x000a0;</bold></p>
        <p>&#x000a0; &#x000a0;B) APGAR score of 5 or less at 10 minutes&#x000a0;<italic toggle="yes"><bold>or</bold></italic> assisted ventilation needed for at least 10 minutes after birth</p>
        <p>It is important to note that the infant must meet either of the above main biochemical criteria to move on to the examination criteria.</p>
        <p>
<bold>Examination Criteria:</bold>
</p>
        <p>The infant must have moderate to severe encephalopathy on an exam, as defined by meeting the criteria of either moderate or severe encephalopathy in at least <bold>3</bold>&#x000a0;of the&#x000a0;6 categories shown below (see <bold>Table.</bold> Examination Criteria).</p>
        <table-wrap id="article-129347.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Examination Criteria</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="text-align: center; width: 160px;" rowspan="1" colspan="1">
<bold>Category</bold>
</td>
                <td style="text-align: center; width: 152px;" rowspan="1" colspan="1">
<bold>Moderate Encephalopathy</bold>
</td>
                <td style="text-align: center; width: 215.337px;" rowspan="1" colspan="1">
<bold>Severe Encephalopathy</bold>
</td>
              </tr>
              <tr>
                <td style="width: 160px;" rowspan="1" colspan="1">
<bold>Level of Consciousness</bold>
</td>
                <td style="width: 152px;" rowspan="1" colspan="1">Lethargic</td>
                <td style="width: 215.337px;" rowspan="1" colspan="1">Stupor or coma</td>
              </tr>
              <tr>
                <td style="width: 160px;" rowspan="1" colspan="1">
<bold>Activity</bold>
</td>
                <td style="width: 152px;" rowspan="1" colspan="1">Decreased</td>
                <td style="width: 215.337px;" rowspan="1" colspan="1">None</td>
              </tr>
              <tr>
                <td style="width: 160px;" rowspan="1" colspan="1">
<bold>Posture</bold>
</td>
                <td style="width: 152px;" rowspan="1" colspan="1">Distal flexion, complete extension</td>
                <td style="width: 215.337px;" rowspan="1" colspan="1">Decerebrate</td>
              </tr>
              <tr>
                <td style="width: 160px;" rowspan="1" colspan="1">
<bold>Primitive Reflexes</bold>
</td>
                <td style="width: 152px;" rowspan="1" colspan="1">Weak suck or incomplete moro</td>
                <td style="width: 215.337px;" rowspan="1" colspan="1">Absent suck or absent moro</td>
              </tr>
              <tr>
                <td style="width: 160px;" rowspan="1" colspan="1">
<bold>Autonomic System</bold>
</td>
                <td style="width: 152px;" rowspan="1" colspan="1">
<p>Constricted pupils, or</p>
<p>Bradycardia, or</p>
<p>Periodic breathing</p>
</td>
                <td style="width: 215.337px;" rowspan="1" colspan="1">
<p>Pupils deviated, dilated, or not reactive to light or</p>
<p>Variable heart rate, or</p>
<p>Apnea</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<italic toggle="yes"><bold>Note</bold>: If the infant is confirmed to be experiencing seizures,&#x000a0;the neonate automatically qualifies by examination criteria, and cooling should&#x000a0;be initiated (assuming the demographic and biochemical criteria are also met). This is because seizures are a sign of HIE, and the rest of the neurological examination would not be accurate while the neonate is experiencing seizures.</italic>
</p>
        <p>If the&#x000a0;infant meets the demographic, biochemical, and&#x000a0;physical exam criteria, the infant qualifies for&#x000a0;therapeutic hypothermia (barring any contraindications below). When an infant qualifies for therapeutic hypothermia, the risks and benefits should be discussed with parents, and cooling should be initiated immediately.</p>
      </sec>
      <sec id="article-129347.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>The exclusion criteria&#x000a0;for&#x000a0;therapeutic hypothermia are as follows:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Gestational age&#x000a0;younger than 36 weeks&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Birth weight &#x0003c; 1800 grams</p>
          </list-item>
          <list-item>
            <p>Older&#x000a0;than 6 hours of age at the time of initiating&#x000a0;therapeutic hypothermia (though some physicians will consider&#x000a0;therapeutic hypothermia for up to 24 hours after birth)</p>
          </list-item>
          <list-item>
            <p>Major congenital abnormality</p>
          </list-item>
          <list-item>
            <p>Death appears inevitable</p>
          </list-item>
          <list-item>
            <p>Life-threatening coagulopathy with significant active bleeding may be an exclusion criterion. However, most infants have mild coagulopathy from the combined effects of asphyxia and cooling. Many infants have an increased rate of mild clinical bleeding&#x000a0;and still benefit from therapeutic hypothermia.<xref ref-type="bibr" rid="article-129347.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p>Neurologically significant head trauma or skull fracture, causing major intracranial hemorrhage. Subgaleal bleeding is a relative contraindication for selective head cooling (SHC). Consider whole-body cooling (WBC) for these infants after initial stabilization.</p>
          </list-item>
          <list-item>
            <p>Imperforate anus is an exclusion criterion for SHC&#x000a0;because rectal temperature recordings can not be obtained. Imperforate anus is not a contraindication for WBC&#x000a0;with an esophageal probe.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-129347.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The required equipment for&#x000a0;therapeutic hypothermia includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cooling device&#x000a0;</p>
          </list-item>
          <list-item>
            <p>A disposable esophageal probe or rectal temperature probe</p>
          </list-item>
          <list-item>
            <p>Overhead warming bed with operative skin temperature probe</p>
          </list-item>
          <list-item>
            <p>Cardiorespiratory monitor</p>
          </list-item>
          <list-item>
            <p>Amplitude-integrated electroencephalography or electroencephalogram (EEG) should be&#x000a0;available at the center (can start after cooling is initiated)</p>
          </list-item>
          <list-item>
            <p>Gel pad for the head (for SHC)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-129347.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>Required personnel for&#x000a0;therapeutic hypothermia include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Neonatologist or pediatrician with knowledge and experience managing critically ill neonates</p>
          </list-item>
          <list-item>
            <p>Registered nurse</p>
          </list-item>
          <list-item>
            <p>Pediatric neurologist (for reading of EEG and possible outpatient follow-up)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-129347.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Before initiating&#x000a0;therapeutic hypothermia, the neonate should have vascular access. Central line access (umbilical arterial and double-lumen umbilical venous) is preferred. If umbilical access is difficult, insert a peripheral intravenous line and, if possible, a peripheral arterial line for continuous blood pressure monitoring. The infant must have a pulse oximeter and a cardiorespiratory&#x000a0;monitor.</p>
        <p>Assess the baseline clinical and neurological status and document this in the chart, including the criteria initially qualifying the neonate for therapeutic hypothermia. It is recommended that baseline labs be sent, including a complete blood count, coagulation profile, a complete metabolic panel, an arterial blood gas, and troponin. The labs should be repeated as needed throughout the cooling process, with the electrolytes repeated at least daily.</p>
      </sec>
      <sec id="article-129347.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Therapeutic hypothermia is administered by SHC or whole-body cooling WBC.&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>SHC&#x000a0;requires a head cap that circulates cold water to decrease the core temperature of the neonate. The head and brain structures reach a cooler temperature than the body. The target temperature in SHC is 34 to 35 &#x000b0;C. Remove the cooling cap every 12 hours to look for an irritative scalp injury due to the cap.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>WBC&#x000a0;requires a special blanket that circulates water, which can be cooled or warmed. WBC achieves uniform cooling of the&#x000a0;entire&#x000a0;body. The target temperature in WBC is 33 to 34 &#x000b0;C.</p>
          </list-item>
        </list>
        <p>Both cooling devices monitor the neonate's temperature with a probe and maintain the desired target temperature by altering the circulating water temperature. Therapeutic hypothermia should last 72 hours, followed by rewarming at 0.5 &#x000b0;C/hour.<xref ref-type="bibr" rid="article-129347.r27">[27]</xref> Passive rewarming will continue for&#x000a0;4 hours in SHC or&#x000a0;6 hours in WBC.</p>
        <p>
<bold>Selective Head Cooling vs Whole-Body Cooling</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>WBC provides uniform cooling to all brain structures, including peripheral and central regions. SHC provides more cooling to the cortical region than to the central structures of the brain.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>WBC offers better or at least similar neuroprotection than SHC based on&#x000a0;EEG and brain magnetic resonance imaging (MRI) findings of treated infants after cooling.<xref ref-type="bibr" rid="article-129347.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>WBC and SHC have similar safety and effectiveness. Also, side effects are similar in both methods.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>WBC is preferred to head cooling in most centers in the United States due to administration ease.</p>
          </list-item>
          <list-item>
            <p>WBC also provides more accessible access to the scalp for EEG monitoring.</p>
          </list-item>
        </list>
        <p>
<bold>Passive Cooling&#x000a0;</bold>
</p>
        <p>If the neonatal unit is not equipped with a cooling facility, consider passive cooling for eligible neonates until they can be transferred to a cooling facility. The practical measures to achieve passive cooling are turning off the warmer or incubator, removing clothes, and not covering the baby with a blanket. The team should monitor the temperature efficiently at least every&#x000a0;15 to&#x000a0;30 minutes. Passive cooling can be an early adjunct to therapeutic hypothermia.<xref ref-type="bibr" rid="article-129347.r29">[29]</xref></p>
      </sec>
      <sec id="article-129347.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Therapeutic hypothermia is usually well-tolerated, but short-term adverse effects are common.</p>
        <list list-type="order">
          <list-item>
            <p>Cardiovascular complications&#x000a0;&#x000a0;
<list list-type="bullet"><list-item><p>Bradycardia- Heart rate decreases 15&#x000a0;beats per minute (bpm)&#x000a0;per 1 &#x000b0;C change in temperature. At 33.5 &#x000b0;C, the heart rate is approximately 80 to 100 bpm. Neonates can tolerate significant bradycardia (60 to 80 bpm) if blood pressure is maintained adequately. If the heart rate is persistently below 60 bpm, obtain a full&#x000a0;EKG.</p></list-item><list-item><p>Hypotension - Hypothermia decreases cardiac output and causes peripheral vasoconstriction, which leads to hypotension. Consider an echocardiogram to assess cardiac output. Maintain mean arterial pressure (MAP) &#x0003e;40 mmHg. Significant hypotension may&#x000a0;necessitate a saline bolus, vasopressors, and steroids.&#x000a0;</p></list-item><list-item><p>Prolonged QT interval and ventricular arrhythmias</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Respiratory complications&#x000a0;
<list list-type="bullet"><list-item><p>Impaired surfactant production</p></list-item><list-item><p>Hypothermia can also cause worsening of oxygenation due to induced pulmonary vasoconstriction and pulmonary hypertension. Pulmonary hypertension is usually reversible with rewarming.</p></list-item><list-item><p>Hypothermia shifts the oxyhemoglobin curve and can result in decreased oxygen delivery.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Electrolyte imbalance
<list list-type="bullet"><list-item><p>Hypokalemia&#x000a0;</p></list-item><list-item><p>Hyponatremia</p></list-item><list-item><p>Hypomagnesemia</p></list-item><list-item><p>Hypophosphatemia</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Coagulopathy, specifically platelet dysfunction</p>
          </list-item>
          <list-item>
            <p>Increased incidence of sepsis due to inhibition of a pro-inflammatory response</p>
          </list-item>
          <list-item>
            <p>Delayed gastric emptying causes intolerance of enteral feeds&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Altered pharmacokinetics and pharmacodynamics of medications like sedatives and analgesics during hypothermia&#x000a0;<xref ref-type="bibr" rid="article-129347.r30">[30]</xref></p>
          </list-item>
        </list>
        <p>&#x000a0;During rewarming, complications can occur as follows:</p>
        <list list-type="order">
          <list-item>
            <p>Seizures due to an increase in cerebral metabolic rate</p>
          </list-item>
          <list-item>
            <p>Apnea</p>
          </list-item>
          <list-item>
            <p>Higher risk of hypotension due to vasodilation of a constricted peripheral vascular bed&#x000a0;<xref ref-type="bibr" rid="article-129347.r31">[31]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-129347.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The "Cool Cap" trial enrolled and&#x000a0;randomly assigned 234 term neonates with moderate or severe&#x000a0;HIE and abnormal&#x000a0;amplitude-integrated EEG to either head cooling (n=116) or conventional management (n=118). The primary outcome measured was death or severe disability at 18 months. Death or disability occurred in 66% of conventional care and 55% of the cooled group (OR 0.61; 95% CI 0.34-1.09;&#x000a0;<italic toggle="yes">P</italic>=0.1). Subgroup analysis revealed that head cooling did not significantly affect neonates with the worse changes in amplitude-integrated EEG (<italic toggle="yes">P</italic>=0.51) but was beneficial in infants with mild amplitude-integrated EEG changes (<italic toggle="yes">P</italic>=0.009). The study suggests that head cooling could safely improve survival without severe neurodevelopmental disability in neonates with less severe amplitude-integrated EEG changes.</p>
        <p>The Total Body Hypothermia (TOBY) trial enrolled and randomly assigned 325 neonates with moderate or severe encephalopathy and abnormal aEEG to whole-body hypothermia or conventional care. The primary outcome measured was death or severe neurodevelopmental disability at 18 months. Death or severe disability occurred in 53% of conventional care cases and 45% of the cooling group (RR 0.86 [0.68 - 1.07];&#x000a0;<italic toggle="yes">P</italic>=0.17). Infants undergoing hypothermia&#x000a0;had an increased survival rate without neurologic deficit (<italic toggle="yes">P&#x000a0;</italic>= 0.003). The TOBY trial suggested that induction of therapeutic hypothermia in infants with perinatal asphyxia did not significantly reduce the combined mortality rate or severe disability but improved neurologic outcomes among survivors.<xref ref-type="bibr" rid="article-129347.r32">[32]</xref></p>
        <p>The NICHD Neonatal Research Network (NRN) trial randomly assigned term infants (n=208) with moderate or severe encephalopathy to WBC to an esophageal temperature of 33.5 &#x000b0;C for 72 hours or usual care. The primary outcome measured was death or disability at 18 months. Whole-body hypothermia decreased mortality or disability in infants with moderate or severe&#x000a0;HIE compared to conservative care (RR 0.72; CI 0.54-0.95; <italic toggle="yes">P</italic>=0.01).<xref ref-type="bibr" rid="article-129347.r1">[1]</xref></p>
        <p>The Infant Cooling Evaluation (ICE) trial (n=221) is the most recent randomized controlled trial published. The mortality or significant disability at&#x000a0;2 years of age occurred in 51% of the cooling group and 66% of the control groups (RR 0.77; CI 0.62 to 0.98). The mortality rate was significantly low, and survival free of disability was higher in the cooling group than in the control group.<xref ref-type="bibr" rid="article-129347.r33">[33]</xref></p>
        <p>A systematic review of 11 randomized controlled trials (n=1505) on cooling for newborns with&#x000a0;HIE suggested that&#x000a0;therapeutic hypothermia benefits neonates with moderate to severe HIE. Therapeutic hypothermia decreased mortality without increasing significant disability among survivors. The benefits of survival and neurodevelopmental outcomes outweighed the short-term adverse effects.<xref ref-type="bibr" rid="article-129347.r9">[9]</xref></p>
      </sec>
      <sec id="article-129347.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Effective use of&#x000a0;therapeutic hypothermia in neonates demands an interprofessional team of healthcare professionals working in a coordinated manner.&#x000a0;Physicians, advanced care practitioners, nurses, pharmacists, and other healthcare professionals have crucial and&#x000a0;specific responsibilities within the neonatal&#x000a0;therapeutic hypothermia team.&#x000a0;Duties range from accurate patient assessment to timely intervention and ongoing monitoring.</p>
        <p>Therapeutic hypothermia involves critical time-sensitive management.&#x000a0;A therapeutic window of 6 hours from birth is crucial. The healthcare team should be aware of therapeutic hypothermia's exclusion criteria. If an eligible neonate is born in a setting without a cooling facility, the referring facility may initiate passive cooling. At the same time, the transport team&#x000a0;must transport the neonate as soon as possible to a facility with cooling capabilities.&#x000a0;&#x000a0;</p>
        <p>Developing a cohesive strategy involves collaborative goal-setting and planning. This includes establishing standardized protocols for therapeutic hypothermia, anticipating potential challenges, and strategizing ways to enhance the efficiency of care delivery.&#x000a0;Though&#x000a0;therapeutic hypothermia is well-tolerated, short-term adverse effects are common with therapeutic hypothermia. The neonate needs continuous monitoring to&#x000a0;assess for complications.&#x000a0;</p>
        <p>Each healthcare professional must possess specialized skills relevant to their role, including proficiency in assessing neonatal conditions, implementing&#x000a0;therapeutic hypothermia protocols, and managing potential complications. Continuous training and updates on best practices are essential to maintain these skills.</p>
        <p>Effective communication is pivotal for successful teamwork. Regular, clear, and respectful communication among interprofessional team members ensures seamless coordination of care, timely response to changing conditions, and shared decision-making. Care coordination involves scheduling interventions, sharing patient information, and aligning treatment plans, ensuring a unified and patient-centered approach. A collaborative and multidisciplinary healthcare team can improve outcomes, prioritize patient safety, and elevate overall team performance in neonatal therapeutic hypothermia.</p>
      </sec>
      <sec id="article-129347.s13" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>The interprofessional team needs to be involved in the care of these neonates. The neonate must be monitored at all times by the bedside nurse to ensure hemodynamic stability and the presence of any complications.</p>
      </sec>
      <sec id="article-129347.s14" sec-type="Nursing, Allied Health, and Interprofessional Team Monitoring">
        <title>Nursing, Allied Health, and Interprofessional Team Monitoring</title>
        <p>Neonatal&#x000a0;therapeutic hypothermia is associated with several physiologic derangements. Frequent monitoring is crucial for the early detection and management of complications.</p>
        <p>
<bold>Cardiovascular:&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Monitor blood pressure, heart rate, and perfusion status</p>
          </list-item>
          <list-item>
            <p>Monitor continuous mean arterial pressure (MAP) through arterial lines</p>
          </list-item>
          <list-item>
            <p>Obtain EKG if there is significant bradycardia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Consider an echocardiogram if persistent hypotension occurs&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
        </list>
        <p><bold>Respiratory</bold>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Initially, frequent blood gas monitoring&#x000a0;(q 4 hrs) may be necessary. The partial pressure of gases depends on the temperature. It is essential to adjust the blood gas machine for the "actual" core temperature before running the sample.</p>
          </list-item>
          <list-item>
            <p>Maintain arterial blood gas pCO2 within the normal range at 38 to 45 mmHg. PaO2 should be &#x0003e;60 and &#x0003c;100 mmHg.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Neurological:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Infants on&#x000a0;therapeutic hypothermia need frequent neurologic assessment. Check pupils and level of consciousness, and look for signs of seizures or raised intracranial pressure.</p>
          </list-item>
          <list-item>
            <p>Neonates may need to receive morphine for cold stress. However, some data suggest that this may prolong the hospital course.<xref ref-type="bibr" rid="article-129347.r34">[34]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Watch for oversedation due to possible accumulation because of altered pharmacokinetics, especially if the neonate is on phenobarbital, as this might mask neurological examination.</p>
          </list-item>
          <list-item>
            <p>Commence an EEG or complete EEG monitoring if possible, at least during the initial cooling and rewarming periods, as seizures are common in this group.</p>
          </list-item>
          <list-item>
            <p>Consider brain MRI at&#x000a0;4 to&#x000a0;10 days of life after the neonate has completed&#x000a0;therapeutic hypothermia when any diffusion-weighted imaging abnormalities are still apparent.<xref ref-type="bibr" rid="article-129347.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p>Pediatric neurology should be consulted to help guide long-term prognosis and follow-up and to help manage seizures should they occur.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Fluid and Electrolytes:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Even though many centers keep infants nil-per-os (NPO) during therapeutic hypothermia, recent studies suggest feeding is not harmful to these infants&#x000a0;and should be implemented as tolerated.<xref ref-type="bibr" rid="article-129347.r36">[36]</xref><xref ref-type="bibr" rid="article-129347.r37">[37]</xref></p>
          </list-item>
          <list-item>
            <p>Start the total fluid rate at 50 to 60 mL/kg/day and adjust based on the baby's clinical status.<xref ref-type="bibr" rid="article-129347.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Maintain glucose and electrolytes within normal limits.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>SIADH (syndrome of inappropriate anti-diuretic hormone)&#x000a0;is also common after perinatal asphyxia. Sodium levels could fall due to increased renal loss in hypothermia.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
        </list>
        <p><bold>Blood work:</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Arterial blood gas, electrolytes, renal function tests, liver function tests, coagulation profiles, and glucose need to be&#x000a0;performed when initiating therapeutic hypothermia and as needed after that.</p>
          </list-item>
        </list>
        <p><bold>Skincare:</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Assessing the integrity of the skin every 6 hours is an integral part of therapeutic hypothermia.</p>
          </list-item>
        </list>
        <p><bold>Strict Infection Control Measures:</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypothermia can cause immune dysfunction; thus,&#x000a0;standard precautions should be observed.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-129347.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=129347&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=129347">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/129347/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=129347">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-129347.s16">
        <title>References</title>
        <ref id="article-129347.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Laptook</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Ehrenkranz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Tyson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Donovan</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Fanaroff</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Poole</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Finer</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Carlo</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Duara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cotten</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Stoll</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Lemons</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Guillet</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jobe</surname>
                <given-names>AH</given-names>
              </name>
              <collab>National Institute of Child Health and Human Development Neonatal Research Network</collab>
            </person-group>
            <article-title>Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.</article-title>
            <source>N Engl J Med</source>
            <year>2005</year>
            <month>Oct</month>
            <day>13</day>
            <volume>353</volume>
            <issue>15</issue>
            <fpage>1574</fpage>
            <page-range>1574-84</page-range>
            <pub-id pub-id-type="pmid">16221780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurinczuk</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>White-Koning</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Badawi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy.</article-title>
            <source>Early Hum Dev</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>86</volume>
            <issue>6</issue>
            <fpage>329</fpage>
            <page-range>329-38</page-range>
            <pub-id pub-id-type="pmid">20554402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palsdottir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dagbjartsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thorkelsson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hardardottir</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Birth asphyxia and hypoxic ischemic encephalopathy, incidence and obstetric risk factors].</article-title>
            <source>Laeknabladid</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>93</volume>
            <issue>9</issue>
            <fpage>595</fpage>
            <page-range>595-601</page-range>
            <pub-id pub-id-type="pmid">17823499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Itoo</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Al-Hawsawi</surname>
                <given-names>ZM</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Hypoxic ischemic encephalopathy. Incidence and risk factors in North Western Saudi Arabia.</article-title>
            <source>Saudi Med J</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>147</fpage>
            <page-range>147-53</page-range>
            <pub-id pub-id-type="pmid">12682677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nencini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Piva</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Scioscia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Volta</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Spadaro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonaccorsi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Greco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cocco</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sorrentino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>D'Antonio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nappi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future.</article-title>
            <source>Acta Neurol Belg</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>120</volume>
            <issue>2</issue>
            <fpage>277</fpage>
            <page-range>277-288</page-range>
            <pub-id pub-id-type="pmid">32112349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Namusoke</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nannyonga</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ssebunya</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nakibuuka</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Mworozi</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Incidence and short term outcomes of neonates with hypoxic ischemic encephalopathy in a Peri Urban teaching hospital, Uganda: a prospective cohort study.</article-title>
            <source>Matern Health Neonatol Perinatol</source>
            <year>2018</year>
            <volume>4</volume>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">29556412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shibasaki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Isayama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takeuchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mukai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ioroi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yutaka</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Iwata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nabetani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iwata</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Three-year outcome following neonatal encephalopathy in a high-survival cohort.</article-title>
            <source>Sci Rep</source>
            <year>2022</year>
            <month>May</month>
            <day>13</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>7945</fpage>
            <pub-id pub-id-type="pmid">35562399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ezenwa</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Olorunfemi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fajolu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Adeniyi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Oleolo-Ayodeji</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kene-Udemezue</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Olamijulo</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ezeaka</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Trends and predictors of in-hospital mortality among babies with hypoxic ischaemic encephalopathy at a tertiary hospital in Nigeria: A retrospective cohort study.</article-title>
            <source>PLoS One</source>
            <year>2021</year>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>e0250633</fpage>
            <pub-id pub-id-type="pmid">33901237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobs</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tarnow-Mordi</surname>
                <given-names>WO</given-names>
              </name>
              <name>
                <surname>Inder</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Cooling for newborns with hypoxic ischaemic encephalopathy.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2013</year>
            <month>Jan</month>
            <day>31</day>
            <volume>2013</volume>
            <issue>1</issue>
            <fpage>CD003311</fpage>
            <pub-id pub-id-type="pmid">23440789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Devi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Pandita</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic Hypothermia for Neonatal Encephalopathy in Low- and Middle-Income Countries: A Meta-Analysis.</article-title>
            <source>Neonatology</source>
            <year>2022</year>
            <volume>119</volume>
            <issue>3</issue>
            <fpage>300</fpage>
            <page-range>300-310</page-range>
            <pub-id pub-id-type="pmid">35340015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballot</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Ramdin</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Bandini</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Nakwa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Velaphi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coetzee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Masemola</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kali</surname>
                <given-names>GJD</given-names>
              </name>
              <name>
                <surname>Horn</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Pillay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Van Rensburg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pepper</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy should not be discontinued in low- and middle-income countries.</article-title>
            <source>S Afr Med J</source>
            <year>2021</year>
            <month>Dec</month>
            <day>02</day>
            <volume>111</volume>
            <issue>12</issue>
            <fpage>1168</fpage>
            <page-range>1168-1169</page-range>
            <pub-id pub-id-type="pmid">34949301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathew</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dsouza</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic Hypothermia for Neonatal Encephalopathy in Low-Resource Settings: Methodological Inaccuracies and Inconsistencies in the Latest Systematic Review.</article-title>
            <source>Neonatology</source>
            <year>2023</year>
            <volume>120</volume>
            <issue>2</issue>
            <fpage>268</fpage>
            <page-range>268-269</page-range>
            <pub-id pub-id-type="pmid">36366813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herrera</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Malcolm</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Pizoli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gustafson</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Cotten</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Bidegain</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of preterm infants treated with hypothermia for hypoxic-ischemic encephalopathy.</article-title>
            <source>Early Hum Dev</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>125</volume>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">30144709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Trivedi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vesoulis</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Smyser</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Mathur</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Safety and Short-Term Outcomes of Therapeutic Hypothermia in Preterm Neonates 34-35 Weeks Gestational Age with Hypoxic-Ischemic Encephalopathy.</article-title>
            <source>J Pediatr</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>183</volume>
            <fpage>37</fpage>
            <page-range>37-42</page-range>
            <pub-id pub-id-type="pmid">27979578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boylan</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Twomey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ahearne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hallberg</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Two-Year Neurodevelopmental Outcomes After Mild Hypoxic Ischemic Encephalopathy in the Era of Therapeutic Hypothermia.</article-title>
            <source>JAMA Pediatr</source>
            <year>2020</year>
            <month>Jan</month>
            <day>01</day>
            <volume>174</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-55</page-range>
            <pub-id pub-id-type="pmid">31710357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berube</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Puia-Dumitrescu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McAdams</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Does mild hypoxic ischemic encephalopathy adversely affect neurodevelopmental outcome?</article-title>
            <source>J Perinatol</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>901</fpage>
            <page-range>901-904</page-range>
            <pub-id pub-id-type="pmid">33714978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laptook</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tyson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Munoz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Ambalavanan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pedroza</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chaudhary</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Ehrenkranz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hensman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Van Meurs</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Chalak</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hamrick</surname>
                <given-names>SEG</given-names>
              </name>
              <name>
                <surname>Sokol</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Poindexter</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Faix</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Watterberg</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Frantz</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Guillet</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Devaskar</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Truog</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Chock</surname>
                <given-names>VY</given-names>
              </name>
              <name>
                <surname>Wyckoff</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>McGowan</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Carlton</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Harmon</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Brumbaugh</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Cotten</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Hibbs</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network</collab>
            </person-group>
            <article-title>Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Oct</month>
            <day>24</day>
            <volume>318</volume>
            <issue>16</issue>
            <fpage>1550</fpage>
            <page-range>1550-1560</page-range>
            <pub-id pub-id-type="pmid">29067428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wall&#x000f8;e</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hjort</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Thoresen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Major concerns about late hypothermia study.</article-title>
            <source>Acta Paediatr</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>108</volume>
            <issue>4</issue>
            <fpage>588</fpage>
            <page-range>588-589</page-range>
            <pub-id pub-id-type="pmid">30417430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Laptook</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tyson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Poindexter</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Schibler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Heyne</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Pedroza</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Van Meurs</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Huitema</surname>
                <given-names>CMP</given-names>
              </name>
              <name>
                <surname>Grisby</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Devaskar</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ehrenkranz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Harmon</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Chalak</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>DeMauro</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hartley-McAndrew</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ambalavanan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brumbaugh</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Watterberg</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Shepherd</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Hamrick</surname>
                <given-names>SEG</given-names>
              </name>
              <name>
                <surname>Barks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cotten</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kilbride</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network</collab>
            </person-group>
            <article-title>Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Jul</month>
            <day>04</day>
            <volume>318</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-67</page-range>
            <pub-id pub-id-type="pmid">28672318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Douglas-Escobar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Hypoxic-ischemic encephalopathy: a review for the clinician.</article-title>
            <source>JAMA Pediatr</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>169</volume>
            <issue>4</issue>
            <fpage>397</fpage>
            <page-range>397-403</page-range>
            <pub-id pub-id-type="pmid">25685948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bennet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roelfsema</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pathipati</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Quaedackers</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Relationship between evolving epileptiform activity and delayed loss of mitochondrial activity after asphyxia measured by near-infrared spectroscopy in preterm fetal sheep.</article-title>
            <source>J Physiol</source>
            <year>2006</year>
            <month>Apr</month>
            <day>01</day>
            <volume>572</volume>
            <issue>Pt 1</issue>
            <fpage>141</fpage>
            <page-range>141-54</page-range>
            <pub-id pub-id-type="pmid">16484298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunn</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>de Haan</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Gluckman</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs.</article-title>
            <source>J Clin Invest</source>
            <year>1997</year>
            <month>Jan</month>
            <day>15</day>
            <volume>99</volume>
            <issue>2</issue>
            <fpage>248</fpage>
            <page-range>248-56</page-range>
            <pub-id pub-id-type="pmid">9005993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bennet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Van den Heuij</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Derrick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Groenendaal</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>van Bel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Juul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Back</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Northington</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Mallard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Cell therapy for neonatal hypoxia-ischemia and cerebral palsy.</article-title>
            <source>Ann Neurol</source>
            <year>2012</year>
            <month>May</month>
            <volume>71</volume>
            <issue>5</issue>
            <fpage>589</fpage>
            <page-range>589-600</page-range>
            <pub-id pub-id-type="pmid">22522476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiang</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lien</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Serum Lactate, Brain Magnetic Resonance Imaging and Outcome of Neonatal Hypoxic Ischemic Encephalopathy after Therapeutic Hypothermia.</article-title>
            <source>Pediatr Neonatol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-40</page-range>
            <pub-id pub-id-type="pmid">26141483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drury</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Bennet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of hypothermic neuroprotection.</article-title>
            <source>Semin Fetal Neonatal Med</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>287</fpage>
            <page-range>287-92</page-range>
            <pub-id pub-id-type="pmid">20646974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic Hypothermia and the Risk of Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>94</volume>
            <issue>47</issue>
            <fpage>e2152</fpage>
            <pub-id pub-id-type="pmid">26632746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tagin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Woolcott</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Vincer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Whyte</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Stinson</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis.</article-title>
            <source>Arch Pediatr Adolesc Med</source>
            <year>2012</year>
            <month>Jun</month>
            <day>01</day>
            <volume>166</volume>
            <issue>6</issue>
            <fpage>558</fpage>
            <page-range>558-66</page-range>
            <pub-id pub-id-type="pmid">22312166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goenka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yozawitz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Nafday</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Selective Head versus Whole Body Cooling Treatment of Hypoxic-Ischemic Encephalopathy: Comparison of Electroencephalogram and Magnetic Resonance Imaging Findings.</article-title>
            <source>Am J Perinatol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>37</volume>
            <issue>12</issue>
            <fpage>1264</fpage>
            <page-range>1264-1270</page-range>
            <pub-id pub-id-type="pmid">31344712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Longhofer</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>McRay</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Passive cooling to initiate hypothermia for transported encephalopathic newborns.</article-title>
            <source>J Perinatol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>9</issue>
            <fpage>592</fpage>
            <page-range>592-3</page-range>
            <pub-id pub-id-type="pmid">17724456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zanelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Buck</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fairchild</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Physiologic and pharmacologic considerations for hypothermia therapy in neonates.</article-title>
            <source>J Perinatol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>377</fpage>
            <page-range>377-86</page-range>
            <pub-id pub-id-type="pmid">21183927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic hypothermia for neonatal encephalopathy.</article-title>
            <source>Curr Treat Options Neurol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>608</fpage>
            <page-range>608-19</page-range>
            <pub-id pub-id-type="pmid">23007949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azzopardi</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Strohm</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Dyet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Halliday</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Juszczak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kapellou</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Levene</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marlow</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thoresen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Whitelaw</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brocklehurst</surname>
                <given-names>P</given-names>
              </name>
              <collab>TOBY Study Group</collab>
            </person-group>
            <article-title>Moderate hypothermia to treat perinatal asphyxial encephalopathy.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Oct</month>
            <day>01</day>
            <volume>361</volume>
            <issue>14</issue>
            <fpage>1349</fpage>
            <page-range>1349-58</page-range>
            <pub-id pub-id-type="pmid">19797281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobs</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Morley</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Inder</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Kirpalani</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Darlow</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>LW</given-names>
              </name>
              <collab>Infant Cooling Evaluation Collaboration</collab>
            </person-group>
            <article-title>Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial.</article-title>
            <source>Arch Pediatr Adolesc Med</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>165</volume>
            <issue>8</issue>
            <fpage>692</fpage>
            <page-range>692-700</page-range>
            <pub-id pub-id-type="pmid">21464374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liow</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Montaldo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lally</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Teiserskas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bassett</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mendoza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Slater</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thayyil</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Preemptive Morphine During Therapeutic Hypothermia After Neonatal Encephalopathy: A Secondary Analysis.</article-title>
            <source>Ther Hypothermia Temp Manag</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-52</page-range>
            <pub-id pub-id-type="pmid">30807267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bednarek</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mathur</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Inder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Neil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shimony</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Impact of therapeutic hypothermia on MRI diffusion changes in neonatal encephalopathy.</article-title>
            <source>Neurology</source>
            <year>2012</year>
            <month>May</month>
            <day>01</day>
            <volume>78</volume>
            <issue>18</issue>
            <fpage>1420</fpage>
            <page-range>1420-7</page-range>
            <pub-id pub-id-type="pmid">22517107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gale</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Longford</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Jeyakumaran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ougham</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Battersby</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ojha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dorling</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Feeding during neonatal therapeutic hypothermia, assessed using routinely collected National Neonatal Research Database data: a retrospective, UK population-based cohort study.</article-title>
            <source>Lancet Child Adolesc Health</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>408</fpage>
            <page-range>408-416</page-range>
            <pub-id pub-id-type="pmid">33891879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hua</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Early versus delayed enteral nutrition for neonatal hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia: a randomized controlled trial.</article-title>
            <source>Ital J Pediatr</source>
            <year>2022</year>
            <month>Aug</month>
            <day>15</day>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>146</fpage>
            <pub-id pub-id-type="pmid">35971138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-129347.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mosalli</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Whole body cooling for infants with hypoxic-ischemic encephalopathy.</article-title>
            <source>J Clin Neonatol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-6</page-range>
            <pub-id pub-id-type="pmid">24027701</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
